The mTOR pathway, which is also regulated by the AMPK pathway, plays a pivotal role in metabolic regulation and is critically involved in the pathogenesis of MASLD. This evidence concerns the gene PRKAA2 and metabolic dysfunction-associated steatotic liver disease.